CSL Behring Medical Expert Portal is a European webpage designed for healthcare professionals (HCPs) who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available. If you are interested in the relevant content for a specific country, please refer to the CSL Behring affiliate in your country to obtain relevant information. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. It is important that you always adhere to the regulations and guidelines relevant to your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Symposia replays

ESID 2024 symposium: InSIDious

Pathology:

Secondary Immunodeficiency

Duration: 1 hr 29 min

ESID, 21st Biennial Meeting of the European Society for Immunodeficiencies, 16–19 October 2024

Click the video above to watch the full recording of the ESID CSL Behring Symposium, InSIDious, held on Wednesday 16 October, 2024.

The symposium featured presentations from chair Stephen Jolles (UK), Mari Campbell (UK) and Emily Carne (UK). The expert faculty shared their insights into the hidden impact of secondary immunodeficiency (SID), covering the psychological impact of living with immunodeficiency, perspectives on SID in haematology, and how the treatment burden of SID can be improved.

Please note that this symposium contains information on specific products and indications. The Summary of Product Characteristics (SmPC) provided may vary depending on local approval in each country. Best efforts were undertaken by CSL Behring and congress sponsors to ensure compliance with EFPIA Code of Practice in line with the Joint Guidelines (IFPMA, EFPIA and PhRMA). However, you should review your local prescribing information and/or SmPC and consult directly with the local affiliate of CSL Behring to address any questions.